Waksman R - Search Results

1

A critical appraisal of the safety and efficacy of drug-eluting stents.

Maluenda G, Lemesle G, Waksman R. Maluenda G, et al. Among authors: waksman r. Clin Pharmacol Ther. 2009 May;85(5):474-80. doi: 10.1038/clpt.2009.8. Epub 2009 Mar 11. Clin Pharmacol Ther. 2009. PMID: 19279567 Review.

2

Effects of 32P radioactive stents on in-stent restenosis in a double stent injury model of the porcine coronary arteries.

Kim HS, Chan RC, Kollum M, Au A, Tio FO, Yazdi HA, Ajani AE, Waksman R. Kim HS, et al. Among authors: waksman r. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1058-63. doi: 10.1016/s0360-3016(01)02601-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11704331

3

Vascular brachytherapy: applications in the era of drug-eluting stents.

Waksman R. Waksman R. Rev Cardiovasc Med. 2002;3 Suppl 5:S23-30. Rev Cardiovasc Med. 2002. PMID: 12478232 Review.

4

Contemporary revascularization strategies in 2002.

Ajani AE, Waksman R. Ajani AE, et al. Among authors: waksman r. Drugs Today (Barc). 2002 May;38(5):309-19. doi: 10.1358/dot.2002.38.5.677134. Drugs Today (Barc). 2002. PMID: 12532167 Review.

5

Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.

Waksman R, Weinberger J. Waksman R, et al. Circulation. 2003 Jul 29;108(4):386-8. doi: 10.1161/01.CIR.0000082928.33891.B7. Circulation. 2003. PMID: 12885731 Review. No abstract available.

6

Drug-eluting stents: from bench to bed.

Waksman R. Waksman R. Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):226-41. doi: 10.1016/s1522-1865(03)00115-x. Cardiovasc Radiat Med. 2002. PMID: 12974379 Review.

7

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.

Waksman R, Ajani AE, Pichard AD, Torguson R, Pinnow E, Canos D, Satler LF, Kent KM, Kuchulakanti P, Pappas C, Gambone L, Weissman N, Abbott MC, Lindsay J; Oral Rapamune to Inhibit Restenosis study. Waksman R, et al. J Am Coll Cardiol. 2004 Oct 6;44(7):1386-92. doi: 10.1016/j.jacc.2004.06.069. J Am Coll Cardiol. 2004. PMID: 15464317 Free article. Clinical Trial.

8

Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent.

Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Fournadjiev JA, Pinnow E, Gebreeyesus A, Aggrey G, Wang Z, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: waksman r. Am J Cardiol. 2004 Oct 15;94(8):1047-50. doi: 10.1016/j.amjcard.2004.06.065. Am J Cardiol. 2004. PMID: 15476623

9

Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.

Kuchulakanti P, Waksman R. Kuchulakanti P, et al. Among authors: waksman r. Drugs. 2004;64(21):2379-88. doi: 10.2165/00003495-200464210-00001. Drugs. 2004. PMID: 15481997 Review.

10

Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis.

Wolfram R, Cheneau E, Mintz GS, Pichard AD, Satler LF, Kent KM, Suddath WO, Pinnow EE, Waksman R. Wolfram R, et al. Among authors: waksman r. Am J Cardiol. 2004 Dec 15;94(12):1551-4. doi: 10.1016/j.amjcard.2004.08.037. Am J Cardiol. 2004. PMID: 15589015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,373 results

Search Page